ARCT
ARCT
US03969T1097
Arcturus Therapeutics Holdings
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 67.221.000 138.389.000
51.4%
Cost of Revenue -- --
--
Gross Profit -- --
--
143.481.000 234.058.000
38.7%
Operating Income -76.260.000 -95.669.000
20.3%
Pretax Income -65.783.000 -80.945.000
18.7%
Net Income Common Stockholders -65.783.000 -80.941.000
18.7%
-- --
--
-- --
--
ende